Stockreport

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

Waldencast Acquisition Corp. - Class A Ordinary Share  (WALD) 
PDF Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth [Read more]